STOCK TITAN

[Form 4] Ingredion Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Stephan B. Tanda, a director of Ingredion Inc (INGR), reported an acquisition of common stock on 09/30/2025. The filing shows 321 shares were acquired at a price of $124.49 as part of the company's annual director retainer. After the transaction Mr. Tanda beneficially owned 1,186 shares directly and 8,800 shares indirectly through The Tanda Joint Living Trust. The Form 4 was filed by one reporting person and is signed by attorney-in-fact Michael N. Levy on 10/02/2025.

Stephan B. Tanda, direttore di Ingredion Inc (INGR), ha riportato un'acquisizione di azioni ordinarie in data 30/09/2025. La pratica mostra che sono state acquisite 321 azioni al prezzo di $124,49 nell'ambito del compenso annuale del direttore della società. Dopo la transazione, il signor Tanda deteneva direttamente 1.186 azioni e indirettamente 8.800 azioni tramite The Tanda Joint Living Trust. Il Form 4 è stato presentato da una persona dichiarata e è firmato dall'avvocato-in-fatto Michael N. Levy il 02/10/2025.

Stephan B. Tanda, director de Ingredion Inc (INGR), informó sobre una adquisición de acciones ordinarias el 30/09/2025. La declaración indica que se adquirieron 321 acciones a un precio de $124,49 como parte del sueldo anual del director de la empresa. Después de la operación, el Sr. Tanda poseía directamente 1.186 acciones y 8.800 acciones indirectamente a través de The Tanda Joint Living Trust. El Formulario 4 fue presentado por una persona informante y está firmado por el apoderado Michael N. Levy el 02/10/2025.

Ingredion Inc(INGR)의 이사 Stephan B. Tanda가 2025년 9월 30일 일반주를 취득했다고 보고했습니다. 공시에 따르면 회사의 연간 이사 보수의 일부로 124.49달러의 가격에 321주가 매입되었습니다. 거래 후 Tanda 씨는 직접 1,186주, The Tanda Joint Living Trust를 통해 간접적으로 8,800주를 보유하게 되었습니다. Form 4는 한 명의 보고자에 의해 제출되었고 2025년 10월 2일에 사실대리인 Michael N. Levy가 서명했습니다.

Stephan B. Tanda, administrateur de Ingredion Inc (INGR), a signalé l'acquisition d'actions ordinaires le 30/09/2025. Le dossier indique que 321 actions ont été achetées à un prix de 124,49 dollars dans le cadre du rétention annuelle du directeur de la société. Après la transaction, M. Tanda détenait directement 1 186 actions et indirectement 8 800 actions par le biais du The Tanda Joint Living Trust. Le Form 4 a été déposé par une seule personne déclarant et est signé par le procureur en fait Michael N. Levy le 02/10/2025.

Stephan B. Tanda, Direktor von Ingredion Inc (INGR), meldete am 30.09.2025 den Erwerb von Stammaktien. Die Einreichung zeigt, dass 321 Aktien zu einem Preis von 124,49 $ im Rahmen der jährlichen Direktorenvergütung erworben wurden. Nach der Transaktion besaß Herr Tanda direkt 1.186 Aktien und indirekt 8.800 Aktien über den The Tanda Joint Living Trust. Das Formular 4 wurde von einer meldenden Person eingereicht und am 02.10.2025 von Rechtsbeistand Michael N. Levy unterschrieben.

ستيفان ب. تاندا، مدير في Ingredion Inc (INGR)، أبلغ عن شراء أسهم عادية في 30/09/2025. يظهر الملف أن 321 سهماً اشتريَت بسعر 124.49 دولار أمريكي كجزء من مكافأة/director retainer السنوية للشركة. بعد الصفقة، امتلك السيد تاندا 1,186 سهماً بشكل مباشر و8,800 سهماً بشكل غير مباشر من خلال The Tanda Joint Living Trust. تم تقديم النموذج 4 من قِبل شخص واحد مُبلغ، وهو موقّع من وكيل-بالنيابة Michael N. Levy في 02/10/2025.

Stephan B. Tanda,Ingredion Inc(INGR)的董事,已在2025年9月30日提交了普通股的取得信息。 文件显示在公司年度董事报酬计划中以每股124.49美元的价格购入了321股。交易完成后,Tanda先生直接持有1,186股,通过The Tanda Joint Living Trust间接持有8,800股。Form 4由一名申报人提交,并由事实代理人Michael N. Levy于2025年10月2日签名。

Positive
  • Transparent disclosure of director compensation via equity grant filed under Section 16
  • Acquisition recorded as annual retainer, indicating routine governance practice rather than opportunistic trading
Negative
  • None.

Insights

TL;DR: Director received equity retainer and marginally increased direct holdings; routine governance disclosure with limited market impact.

The reported 321-share acquisition at $124.49 reflects a standard equity retainer for outside directors rather than open-market trading or a change in control position. Holdings after the grant total 1,186 shares direct and 8,800 indirect, indicating most economic exposure is held via a family trust. This disclosure is procedural and complies with Section 16 reporting requirements; it does not by itself signal a change in board composition or company strategy.

TL;DR: Form 4 timely reports a compensatory stock grant to a director; no material red flags noted in the filing.

The form identifies the transaction as code A and includes an explanatory note that shares were issued to outside directors as part of their annual retainer. The single-person filing and attorney-in-fact signature indicate standard processing. There are no dispositions, derivative transactions, or unexplained date irregularities present in the record provided.

Stephan B. Tanda, direttore di Ingredion Inc (INGR), ha riportato un'acquisizione di azioni ordinarie in data 30/09/2025. La pratica mostra che sono state acquisite 321 azioni al prezzo di $124,49 nell'ambito del compenso annuale del direttore della società. Dopo la transazione, il signor Tanda deteneva direttamente 1.186 azioni e indirettamente 8.800 azioni tramite The Tanda Joint Living Trust. Il Form 4 è stato presentato da una persona dichiarata e è firmato dall'avvocato-in-fatto Michael N. Levy il 02/10/2025.

Stephan B. Tanda, director de Ingredion Inc (INGR), informó sobre una adquisición de acciones ordinarias el 30/09/2025. La declaración indica que se adquirieron 321 acciones a un precio de $124,49 como parte del sueldo anual del director de la empresa. Después de la operación, el Sr. Tanda poseía directamente 1.186 acciones y 8.800 acciones indirectamente a través de The Tanda Joint Living Trust. El Formulario 4 fue presentado por una persona informante y está firmado por el apoderado Michael N. Levy el 02/10/2025.

Ingredion Inc(INGR)의 이사 Stephan B. Tanda가 2025년 9월 30일 일반주를 취득했다고 보고했습니다. 공시에 따르면 회사의 연간 이사 보수의 일부로 124.49달러의 가격에 321주가 매입되었습니다. 거래 후 Tanda 씨는 직접 1,186주, The Tanda Joint Living Trust를 통해 간접적으로 8,800주를 보유하게 되었습니다. Form 4는 한 명의 보고자에 의해 제출되었고 2025년 10월 2일에 사실대리인 Michael N. Levy가 서명했습니다.

Stephan B. Tanda, administrateur de Ingredion Inc (INGR), a signalé l'acquisition d'actions ordinaires le 30/09/2025. Le dossier indique que 321 actions ont été achetées à un prix de 124,49 dollars dans le cadre du rétention annuelle du directeur de la société. Après la transaction, M. Tanda détenait directement 1 186 actions et indirectement 8 800 actions par le biais du The Tanda Joint Living Trust. Le Form 4 a été déposé par une seule personne déclarant et est signé par le procureur en fait Michael N. Levy le 02/10/2025.

Stephan B. Tanda, Direktor von Ingredion Inc (INGR), meldete am 30.09.2025 den Erwerb von Stammaktien. Die Einreichung zeigt, dass 321 Aktien zu einem Preis von 124,49 $ im Rahmen der jährlichen Direktorenvergütung erworben wurden. Nach der Transaktion besaß Herr Tanda direkt 1.186 Aktien und indirekt 8.800 Aktien über den The Tanda Joint Living Trust. Das Formular 4 wurde von einer meldenden Person eingereicht und am 02.10.2025 von Rechtsbeistand Michael N. Levy unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Tanda Stephan B.

(Last) (First) (Middle)
5 WESTBROOK CORPORATE CENTER

(Street)
WESTCHESTER IL 60154

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ingredion Inc [ INGR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/30/2025 A 321(1) A $124.49 1,186 D
Common Stock 8,800 I through The Tanda Joint Living Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These are shares of common stock issued to the Company's outside directors as part of their annual retainer.
Michael N. Levy, attorney-in-fact 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ingredion director Stephan B. Tanda report on Form 4 (INGR)?

He reported acquiring 321 shares of Ingredion common stock on 09/30/2025 at a price of $124.49 per share as part of his annual director retainer.

How many Ingredion shares does Stephan B. Tanda beneficially own after the reported transaction?

After the transaction he beneficially owned 1,186 shares directly and 8,800 shares indirectly through The Tanda Joint Living Trust.

Was the Form 4 filed jointly or by a single reporting person for INGR?

The Form 4 was filed by one reporting person (Stephan B. Tanda).

What is the reason given for the share acquisition in the INGR Form 4?

The filing explains these shares were issued to the company's outside directors as part of their annual retainer.

Who signed the Form 4 for Stephan B. Tanda and when?

The form shows Michael N. Levy, attorney-in-fact signed on 10/02/2025.
Ingredion Inc

NYSE:INGR

INGR Rankings

INGR Latest News

INGR Latest SEC Filings

INGR Stock Data

7.68B
63.66M
0.74%
93.69%
3.01%
Packaged Foods
Grain Mill Products
Link
United States
WESTCHESTER